CELGENE CORP /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CELGENE CORP /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is a 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and a in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and a 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and a in ACCELERON PHARMA INC ($XLRN) and a 10% Owner in ACCELERON PHARMA INC ($XLRN) and a in SUTRO BIOPHARMA INC ($STRO) and a 10% Owner in Abraxis BioScience, Inc. ($ABII) and a 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and a 10% Owner in CRISPR Therapeutics AG ($CRSP).

Over the past year CELGENE CORP /DE/ has been an insider in 3 companies. The total value of shares held by CELGENE CORP /DE/ in these companies amounts to $1,343,680,537.

CELGENE CORP /DE/ 10% Owner
Abraxis BioScience, Inc.
10% Owner
ACCELERON PHARMA INC
10% Owner
Adynxx, Inc.
10% Owner
AGIOS PHARMACEUTICALS, INC.
10% Owner
BRISTOL MYERS SQUIBB CO
10% Owner
CASI Pharmaceuticals, Inc.
10% Owner
CELGENE CORP /DE/
10% Owner
CRISPR Therapeutics AG
SUTRO BIOPHARMA, INC.
$ 1343680537 The total value of shares held by CELGENE CORP /DE/
Insider Rank

CELGENE CORP /DE/ ranks 65 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 86 MORRIS AVENUE SUMMIT 07901 NJ

Companies in which CELGENE CORP /DE/ is an Insider

Abraxis BioScience, Inc.

Trading Symbol: ABII
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 100 shares
Latest Transaction: Oct 18 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $166,435,229
Latest Transaction: Jul 13 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 1x
Shares Bought: 1,598,885
Shares Sold: 2,241
Share Difference: +1,596,644
Value Difference: -$67,953,739

Adynxx, Inc.

Trading Symbol: ALQA
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,342,377 shares
Current Value: $4,038,307
Latest Transaction: Apr 13 2017
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 4,296,277
Shares Sold: 0
Share Difference: +4,296,277
Value Difference: -$2,000,000

AGIOS PHARMACEUTICALS, INC.

Trading Symbol: AGIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 1,777,824 shares
Current Value: $78,970,942
Latest Transaction: Nov 14 2019
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,254,379
Shares Sold: 0
Share Difference: +1,254,379
Value Difference: -$69,527,295

BRISTOL MYERS SQUIBB CO

Trading Symbol: BMY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $362,175,397
Latest Transaction: Jul 13 2020
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 1x
Shares Bought: 147,087
Shares Sold: 2,241
Share Difference: +144,846
Value Difference: -$9,999,977

CASI Pharmaceuticals, Inc.

Trading Symbol: CASI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 23,750,000 shares
Current Value: $33,012,500
Latest Transaction: Apr 01 2005
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CELGENE CORP /DE/

Trading Symbol: CELG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $815,069,911
Latest Transaction: Jul 13 2020
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 11x
Sell: 22x
Shares Bought: 13,710,718
Shares Sold: 1,114,687
Share Difference: +12,596,031
Value Difference: -$129,565,014

CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 4,812,221 shares
Current Value: $75,792,481
Latest Transaction: Dec 07 2017
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 21x
Shares Bought: 4,834,980
Shares Sold: 1,112,446
Share Difference: +3,722,534
Value Difference: +$9,916,020

SUTRO BIOPHARMA, INC.

Trading Symbol: STRO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/:
Holdings: 1,726,197 shares
Latest Transaction: Oct 02 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 1,726,197
Shares Sold: 0
Share Difference: +1,726,197
Value Difference: $0

Latest Insider Trading Transactions of CELGENE CORP /DE/

Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970

View all CELGENE CORP /DE/ insider transactions.